A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
NCT05740956
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
318
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Prostatic Cancer
Colorectal Cancer
Interventions
DRUG:
HS-10502
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.